−7.54USD
−12.203MUSD
9.412MUSD
1.356M
About Precipio, Inc.
Sector
Industry
CEO
Ilan Danieli
Website
Headquarters
New Haven
Employees (FY)
55
Founded
1997
ISIN
US74019L6020
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
$PRPO entry PT 1.86-1.98 Target PTs 4-4.50-8 and higherPrecipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or b
PRPO 1Mtest
$0.05-$0.07 -> $0.59 Nice Play
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScre
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
